DDP225

· Dynogen Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DDP225, covering 2007-10-12 to 2007-10-15. Get the full timeline:

Most recent: Clinical Trial Update: 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS [Phase 2]